Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients

World Journal of Surgical Oncology

Volumn 9, Issue , 2011, Pages

  Park, Sung Taek ^a   Song, Min Jong ^b   Park, Jong Sup ^a   Hur, Soo Young ^a   Lee, Chung Won ^c  

^a The Catholic University of Korea   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Cervical carcinoma; Clinicopathologic behavior; Human papillomavirus; Renal transplantation

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; VIRUS DNA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; DIALYSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NONHUMAN; RETROSPECTIVE STUDY; THYROID CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS DETECTION; VIRUS TYPING; WART VIRUS; ALLOTRANSPLANTATION; CANCER STAGING; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; HEALTH SURVEY; INCIDENCE; RISK FACTOR; SOUTH KOREA; UTERINE CERVIX TUMOR;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEOPLASM STAGING; POPULATION SURVEILLANCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; UTERINE CERVICAL NEOPLASMS;

EID: 79960123796     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-9-72     Document Type: Article

References (39)

1. Penn I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 1978, 83:492-502.
2. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant patients. Lancet 1995, 346:403-406. 10.1016/S0140-6736(95)92780-8, 7623570.
3. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohmé I, Forsberq B, Eklund B, Fieldborg O, Friedberg M, Frödin L, Glattre E, Halvorsen S, Holm NV, Jakobsen A, Jorgensen HE, Ladefoged J, Lindholm T, Lundgren G, Pukkala E. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995, 60:183-189. 10.1002/ijc.2910600209, 7829213.
4. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004, 4:905-913. 10.1111/j.1600-6143.2004.00450.x, 15147424.
5. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005, 80(2 suppl):S254-264.
6. Andrés A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol 2005, 56:71-85. 10.1016/j.critrevonc.2004.11.010, 15978827.
7. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Post-transplant de no vo malignancies in renal transplant recipients: The past and present. Transpl Int 2006, 19:607-620. 10.1111/j.1432-2277.2006.00330.x, 16827677.
8. Penn I. Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet 1986, 162:603-610.
9. Paternoster DM, Cester M, Resente C, Pascoli I, Nanhorngue K, Marchini F, Boccagni P, Cillo U, Ribaldone R, Amoruso E, Cocca N, Cuccolo V, Bertolino M, Surico N, Stratta P. Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients. Transplant Proc 2008, 40:1877-1880. 10.1016/j.transproceed.2008.05.074, 18675077.
10. Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer 2005, 15:727-746. 10.1111/j.1525-1438.2005.00246.x, 16174218.
11. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992, 327:1272-1278. 10.1056/NEJM199210293271804, 1328880.
12. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999, 180:1415-1423. 10.1086/315086, 10515798.
13. Jung ES, Shin JH, Lee KJ, Kim DC, Lee A, Choi YJ. HPV in situ hybridization and immunohistochemical expression of L1 capsid protein in cervical intraepithelial neoplasia. Korean J Obstet Gynecol 2009, 52:1279-1286.
14. Shibata DK, Arnheim N, Martin WJ. Detection of human papilloma virus in paraffin- embedded tissue using the polymerase chain reaction. J Exp Med 1988, 167:225-230. 10.1084/jem.167.1.225, 2188813, 2826637.
15. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527. 10.1056/NEJMoa021641, 12571259.
16. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE. Cancer incidence before and after kidney transplantation. JAMA 2006, 296:2823-2831. 10.1001/jama.296.23.2823, 17179459.
17. Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007, 7:941-8. 10.1111/j.1600-6143.2007.01736.x, 17331115.
18. Adami J, Gäbel H, Lindelöf B, Ekström K, Rydh B, Glimelius B, Ekbom A, Adami HO, Granath F. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003, 89:1221-1227. 10.1038/sj.bjc.6601219, 2394311, 14520450.
19. Ju MK, Joo DJ, Kim SJ, Huh KH, Kim MS, Jeon KO, Kim HJ, Kim SI, Kim YS. Chronologically different incidence of post-renal transplant malignancies in renal transplant recipients: single center experience. Transpl Int 2009, 22:644-653. 10.1111/j.1432-2277.2009.00846.x, 19220824.
20. Lee J, Jeong JJ, Lee YS, Nam KH, Chang HS, Chung WY, Soh EY, Park CS. Incidence and clinical behavior of papillary thyroid carcinoma in renal allograft recipients: A single center experience. Transplant Proc 2008, 40:3751-3754. 10.1016/j.transproceed.2008.07.127, 19100481.
21. Park JH, Park JH, Bok HJ, Kim BS, Yang CW, Kim YS, Kim SY, Moon IS, Koh YB, Bamg BK. Posttransplant malignancy during 30 years at a single center. Transplant Proc 2000, 32:1979. 10.1016/S0041-1345(00)01519-0, 11120027.
22. National cancer information center Cancer incidence in Korea 2007. National cancer information center., http://www.cancer.go.kr/cms/statics/incidence/index.html
23. Webster AC, Craig JC, Simpson JM, Jones MP, Chapman JR. Identifying high risk groups and qualifying absolute risk of cancer after kidney transplantation: A cohort study of 15183 recipients. Am J Transplant 2007, 7:2140-2151. 10.1111/j.1600-6143.2007.01908.x, 17640312.
24. Stratta P, Morellini V, Musetti C, Turello E, Palmieri D, Lazzarich E, Cena T, Magnani C. Malignancy after kidney transplantation: results of 400 patients from a single center. Clin Transplant 2008, 22:424-427. 10.1111/j.1399-0012.2008.00802.x, 18312442.
25. Imao T, Ichimaru N, Takahara S, Kokado Y, Okumi M, Imamura R, Namba Y, Isaka Y, Nonomura N, Okuyama. A Risk factors for malignancy in Japanese renal transplant recipients. Cancer 2007, 109:2109-2115. 10.1002/cncr.22636, 17407138.
26. Winkelhorst JT, Brokelman WJ, Tiggeler RG, Wobbes T. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol 2001, 27:409-413. 10.1053/ejso.2001.1119, 11417989.
27. Veroux M, Puliatti C, Fiamingo P, Cappello D, Macarone M, Puliatti D, Vizcarra D, Gagliano M, Veroux P. Early de novo malignancies after kidney transplantation. Transplant Proc 2004, 36:718-720. 10.1016/j.transproceed.2004.03.021, 15110643.
28. Brunner FP, Landais P, Selwood NH. Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association- European Renal Association. Nephrol Dial Transplant 1995, 10(Suppl 1):74-80.
29. Sheil AG. Cancer after transplantation. World J Surg 1986, 10:389-393. 10.1007/BF01655298, 3524027.
30. Brown MR, Noffsinger A, First MR, Penn I, Husseinzadeh N. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol Oncol 2000, 79:220-224. 10.1006/gyno.2000.5942, 11063648.
31. Alloub MI, Barr BB, Mclaren KM, Smith IW, Bunney MH, Smart GE. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ 1989, 298:153-156. 10.1136/bmj.298.6667.153, 1835493, 2538174.
32. Fairley CK, Chen S, Tabrizi SN, McNeil J, Becker G, Walker R, Atkins RC, Thomson N, Allan P, Woodburn C, Garland SM. Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment. Nephrol Dial Transplant 1994, 9:416-420.
33. Veroux M, Corona D, Scalia G, Garozzo V, Gagliano M, Giuffrida G, Costanzo CM, Giaquinta A, Palermo I, Zappalà D, Tallarita T, Zerbo D, Russo R, Cappellani A, Franchina C, Scriffignano V, Veroux P. Surveillance of Human Papilloma Virus Infection and Cervical Cancer in Kidney Transplant Recipients: Preliminary Data. Transplant Proc 2009, 41:1191-1194. 10.1016/j.transproceed.2009.03.015, 19460514.
34. EBPG Expert Group on Renal Transplantation European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.1, Cancer risk after renal transplantation. Nephrol Dial Transplant 2002, 17(Suppl 4):31-33. 35-36, EBPG Expert Group on Renal Transplantation.
35. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD, Singer GG. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000, 11(Suppl 15):S1-S86.
36. Webster AC, Wong G, Craig JC, Chapman JR. Managing cancer risk and decision making after kidney transplantation. Am J Transplant 2008, 8:2185-2191. 10.1111/j.1600-6143.2008.02385.x, 18782291.
37. Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Lulthra R, Lin E, Lai HC, Zhang W, Sneige N. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol 2008, 46:274-280. 10.1128/JCM.01299-07, 2224284, 17977987.
38. Evans MF, Mount SL, Beatty BG, Cooper K. Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia. Mod Pathol 2002, 15:1339-1347. 10.1038/modpathol.3880698, 12481016.
39. Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS, Ramaekers FC. HPV in situ hybridization: impact of different protocols on detection of integrated HPV. Int J Cancer 2005, 115:419-428. 10.1002/ijc.20862, 15688369.